BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 38013262)

  • 1. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer.
    Sun Y; Wang Y; Cheng X; Wu W; Liu Q; Chen X; Ren F
    Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer.
    Li X; Yin Y; Sheng X; Han X; Sun L; Lu C; Wang X
    Radiat Oncol; 2015 Feb; 10():40. PubMed ID: 25886535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of polypoid growth pattern with lymph node involvement in endometrioid type endometrial adenocarcinoma.
    Bezircioglu I; Yetimalar MH; Kilic D; Yigit S
    Indian J Cancer; 2023; 60(2):230-236. PubMed ID: 37530246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lymph node dissection in the surgical treatment of endometrial cancer patients (retrospective analysis).
    Movchan O; Svintsitskyi V
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):63-68. PubMed ID: 36219260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low uterine segment involvement on prognosis of early stage endometrial cancer.
    Akdöner A; Kurt S; Yavuz O; Bayram E; Üresin M; Ulukuş EÇ
    J Obstet Gynaecol Res; 2024 Jun; 50(6):991-1001. PubMed ID: 38575743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive models for lymph node metastasis in endometrial cancer: A systematic review and bibliometric analysis.
    Li H; Wang J; Zhang G; Li L; Shen Z; Zhai Z; Wang Z; Wang J
    Womens Health (Lond); 2024; 20():17455057241248398. PubMed ID: 38725247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological and molecular diagnosis of bilateral inguinal lymph nodes metastases from low-grade endometrial adenocarcinoma: a case report with review of the literature.
    Perrone AM; Girolimetti G; Cima S; Kurelac I; Livi A; Caprara G; Santini D; Castellucci P; Morganti AG; Gasparre G; De Iaco P
    BMC Cancer; 2018 Jan; 18(1):7. PubMed ID: 29295713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical abdomino-pelvic surgery in the management of uterine carcinosarcoma with concomitant para-aortic lymphadenopathy metastasising from anal carcinoma.
    Cowdell I; Smyth SL; Eltawab S; Soleymani Majd H
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36450419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis.
    Mohammed SI; Torres-Luquis O; Zhou W; Lanman NA; Espina V; Liotta L
    Breast Cancer (Dove Med Press); 2020; 12():57-67. PubMed ID: 32273752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma.
    Lundeberg K; Wolford J; Reid T
    Gynecol Oncol Rep; 2024 Jun; 53():101390. PubMed ID: 38623268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian dysgerminoma with a metastasis to para-aortic lymph node.
    Kawase R; Suzuki S
    Clin Case Rep; 2021 Dec; 9(12):e05227. PubMed ID: 34938568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial for "Fully Automated Identification of Lymph Node Metastases and Lymphovascular Invasion in Endometrial Cancer From Multi-Parametric MRI by Deep Learning".
    Takahashi S
    J Magn Reson Imaging; 2024 Apr; ():. PubMed ID: 38662938
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
    Lax SF; Tamussino KF; Lang PF
    Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
    Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
    Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of para-aortic lymphadenectomy in endometrial cancer.
    AlHilli MM; Mariani A
    Int J Clin Oncol; 2013 Apr; 18(2):193-9. PubMed ID: 23412768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the influence of primary uterine tumor site on pelvic and para-aortic lymph node metastatic pattern and evaluating the risk factors for lymph node metastases in endometrial carcinoma: A retrospective study.
    Zhang X; Chen S; Li G; Zheng L; Shang S; Li J; Guan X; Yang J
    Medicine (Baltimore); 2023 Nov; 102(47):e36100. PubMed ID: 38013262
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.